Average Co-Inventor Count = 7.33
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (61 from 214 patents)
2. Other (2 from 832,680 patents)
3. Amgen Inc. (2 from 1,970 patents)
65 patents:
1. 12448373 - Azetidinyl-acetamides as CXCR7 inhibitors
2. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
3. 12268675 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors
4. 12054484 - Substituted tetrahydropyrans as CCR2 modulators
5. 11883391 - Compositions and methods for treating inflammatory bowel disease using CCR9 inhibitor and anti-IL-23 blocking antibodies
6. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
7. 11834452 - CXCR7 antagonists
8. 11807609 - Deuterated compounds as immunomodulators
9. 11773091 - 6-5 fused rings as C5a inhibitors
10. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
11. 11608336 - Prodrugs of fused-bicyclic C5aR antagonists
12. 11603356 - Amorphous form of a complement component C5a receptor
13. 11485737 - Diaryl substituted 5,5-fused ring compounds as C5aR inhibitors
14. 11479553 - 5-5 fused rings as C5a inhibitors
15. 11478460 - Diaryl substituted 6,5-fused ring compounds as C5aR inhibitors